Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OCGN

Ocugen Inc

May 11 • 02:31PM ET

1.49

-0.02 -1.27 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RGNX OCUL EDIT INO NVAX

| Held by: VTI XBI VXF KOMP VHT ITOT IDNA LABU MOON ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.23	Insider Own	2.80%	Shs Outstand	338.32M	Perf Week	-19.42%
Market Cap	504.66M	Forward P/E	178.97	EPS next Y	0.01	Insider Trans	0.00%	Shs Float	329.04M	Perf Month	-15.30%
Enterprise Value	506.10M	PEG	-	EPS next Q	-0.05	Inst Own	22.23%	Short Float	20.63%	Perf Quarter	8.03%
Income	-71.67M	P/S	113.15	EPS this Y	3.11%	Inst Trans	11.16%	Short Ratio	7.87	Perf Half Y	8.03%
Sales	4.46M	P/B	86.88	EPS next Y	103.74%	ROA	-118.11%	Short Interest	67.89M	Perf YTD	10.43%
Book/sh	0.02	P/C	15.84	EPS next 5Y	-	ROE	-660.00%	52W High	2.72 -45.29%	Perf Year	122.51%
Cash/sh	0.09	P/FCF	-	EPS past 3/5Y	17.64% 5.89%	ROIC	-215.58%	52W Low	0.64 132.94%	Perf 3Y	112.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	21.05% 152.94%	Gross Margin	44.48%	Volatility	6.35% 6.30%	Perf 5Y	-84.94%
Dividend TTM	-	EV/Sales	113.48	EPS Y/Y TTM	-24.67%	Oper. Margin	-1483.85%	ATR (14)	0.14	Perf 10Y	-98.26%
Dividend Ex-Date	-	Quick Ratio	1.86	Sales Y/Y TTM	-1.26%	Profit Margin	-1605.22%	RSI (14)	38.46	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.86	EPS Q/Q	-11.41%	SMA20	-12.58%	Beta	2.27	Target Price	11.57
Payout	-	Debt/Eq	5.74	Sales Q/Q	3.51%	SMA50	-19.72%	Rel Volume	1.05	Prev Close	1.51
Employees	116	LT Debt/Eq	4.73	Earnings	May 05 BMO	SMA200	-0.00%	Avg Volume	8.63M	Price	1.49
IPO	Dec 03, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-16.73% 266.92%	Trades		Volume	7,115,199	Change	-1.27%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)